P65L (p.Pro65Leu) variant of IRS1 (Insulin receptor substrate 1)

P65L (p.Pro65Leu) in IRS1 (Insulin receptor substrate 1) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.66 / 1. The record also includes population frequency data.

P65L (p.Pro65Leu) variant details